Compare · CDAK vs PM
CDAK vs PM
Side-by-side comparison of Codiak BioSciences Inc. (CDAK) and Philip Morris International Inc (PM): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CDAK and PM operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
- PM is the larger of the two at $302.25B, about 2413.2x CDAK ($125.2M).
- PM has hit the wire 7 times in the past 4 weeks while CDAK has been quiet.
- PM has more recent analyst coverage (25 ratings vs 2 for CDAK).
- Company
- Codiak BioSciences Inc.
- Philip Morris International Inc
- Price
- -
- -
- Market cap
- $125.2M
- $302.25B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medicinal Chemicals and Botanical Products
- Medicinal Chemicals and Botanical Products
- Exchange
- NASDAQ
- NYSE
- IPO
- 2020
- News (4w)
- 0
- 7
- Recent ratings
- 2
- 25
Codiak BioSciences Inc.
Codiak BioSciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing exosome-based therapeutics for the treatment of oncology, neuro-oncology, neurology, neuromuscular diseases, infectious diseases, and other diseases. Its lead product candidates are exoSTING and exoIL-12, an exosome therapeutic candidates, for the treatment of various solid tumors. The company is also developing exoASO-STAT6, an antisense oligonucleotide targeting the STAT6 transcription factor; exoASO-NLRP3 for multiple sclerosis, neuropathy, and neurodegeneration; and exoVACC, a modular platform for constructing precision vaccines. It has a collaboration agreement with the Jazz Pharmaceuticals Ireland Limited, Sarepta Therapeutics, Inc., Kayla Therapeutics, Washington University, Ragon Institute of MGH, MIT, and Harvard. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
Philip Morris International Inc
Philip Morris International Inc., through its subsidiaries, manufactures and sells cigarettes, other nicotine-containing products, smoke-free products, and related electronic devices and accessories. The company offers IQOS smoke-free products, including heated tobacco and nicotine-containing vapor products under the HEETS, HEETS Creations, HEETS Dimensions, HEETS Marlboro, HEETS FROM MARLBORO, Marlboro Dimensions, Marlboro HeatSticks, and Parliament HeatSticks brands, as well as under the Fiit and Miix licensed brands. It also sells its products under the Marlboro, Parliament, Bond Street, Chesterfield, L&M, Lark, and Philip Morris brands. In addition, the company owns various cigarette brands, such as Dji Sam Soe, Sampoerna A, and Sampoerna U in Indonesia; and Fortune and Jackpot in the Philippines. It markets and sells its products in the European Union, Eastern Europe, the Middle East, Africa, South and Southeast Asia, East Asia, Australia, Latin America, and Canada. Philip Morris International Inc. was incorporated in 1987 and is headquartered in New York, New York.
Latest CDAK
- SEC Form SC 13G/A filed by Codiak BioSciences Inc. (Amendment)
- SEC Form 25-NSE filed by Codiak BioSciences Inc.
- SEC Form SC 13G/A filed by Codiak BioSciences Inc. (Amendment)
- Why Bullfrog AI Holdings Shares Are Trading Higher By 73%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
- Why AMC Entertainment Holdings Shares Are Trading Lower By 25%; Here Are 20 Stocks Moving Premarket
- Stocks That Hit 52-Week Lows On Monday
- SEC Form 4 filed by Howze Yalonda
- SEC Form 4 filed by Sathyanarayanan Sriram
- SEC Form 4 filed by Konstantinov Konstantin
- SEC Form 4 filed by Bain Linda
Latest PM
- Philip Morris International Inc filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- Altria Announces Arrangement with Philip Morris International to Enhance Operational Efficiency
- Philip Morris International Announces Contract Manufacturing Collaboration with Altria
- FDA Authorizes ZYN ULTRA Nicotine Pouches Following Scientific Review
- PMI U.S. Names Five Artists Shaping Modern American Culture for the ZYN America250 Art Series
- New insider Andolina Massimo claimed ownership of 71,588 shares (SEC Form 3)
- SEC Form 25-NSE filed by Philip Morris International Inc
- SEC Form 10-Q filed by Philip Morris International Inc
- BTIG Research initiated coverage on Philip Morris International with a new price target
- Philip Morris International Inc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits